You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rosuvastatin

Showing 26 - 50 of 790
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Tempe (Simvastatin, Rosuvastatin, MGL-3196)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Aug 31, 2022

Ovarian Cancer Trial in Boston (Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis)

Active, not recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Hypercholesterolemia Trial in Cleveland (dietary supplement, drug, other)

Completed
  • Hypercholesterolemia
  • Fish Oil, Cinnamon, Garlique,Turmeric, Plant Sterol, Red Yeast Rice
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic
Aug 1, 2022

ANCA-associated Primary Necrotizing Vasculitides Trial in Paris (Rosuvastatin, Placebo)

Completed
  • ANCA-associated Primary Necrotizing Vasculitides
  • Rosuvastatin
  • Placebo
  • Paris, France
    Hopital Cochin
Oct 10, 2022

Healthy Volunteers Trial in San Francisco (Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag)

Recruiting
  • Healthy Volunteers
  • Rosuvastatin
  • +2 more
  • San Francisco, California
    Ucsf Ctsi Crc
Nov 29, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Canton, Ohio
    Gabrail Cancer Research Center
Apr 25, 2023

Healthy Male Trial in Shanghai (D-1553)

Active, not recruiting
  • Healthy Male
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Oct 23, 2023

Healthy Trial in Pilsen (Dabigatran etexilate, Rosuvastatin, Daridorexant)

Not yet recruiting
  • Healthy
  • Dabigatran etexilate
  • +2 more
  • Pilsen, Czechia
    CEPHA s.r.o.
Aug 2, 2022

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)

Recruiting
  • Healthy Volunteers
  • Dallas, Texas
    Covance Clinical Research Unit - Dallas
Oct 25, 2022

Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Nov 2, 2022

Cirrhosis, Cirrhosis, Liver, Cirrhosis Early Trial in United States (Rosuvastatin)

Not yet recruiting
  • Cirrhosis
  • +10 more
  • Rosuvastatin
  • La Jolla, California
  • +12 more
Apr 14, 2023

Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)

Completed
  • Dyslipidemias
  • Hypertension
  • Rosuampin 10/5mg
  • +2 more
  • Daegu, Korea, Republic of
    Daegu Catholic Univ. Medical Center
Oct 10, 2022

Ezetimibe-Rosuvastatin Evaluation Study

Not yet recruiting
  • Hypercholesterolemia
  • +2 more
    • Athens, Greece
      Athens University Hospital
    May 19, 2022

    Chemo-induced Cardiotoxicity, Breast Cancer Trial in Tanta (Rosuvastatin 20mg)

    Recruiting
    • Chemotherapy-induced Cardiotoxicity
    • Breast Cancer
    • Rosuvastatin 20mg
    • Tanta, Egypt
      The Department of Clinical Oncology, Tanta University Hospital
    Apr 18, 2022

    HIV Trial in Cincinnati (darunavir, ritonavir, rosuvastatin, rosuvastatin, darunavir, ritonavir)

    Completed
    Has Results
    • HIV Infections
    • darunavir, ritonavir, rosuvastatin
    • rosuvastatin, darunavir, ritonavir
    • Cincinnati, Ohio
      University of Cincinnati AIDS Clinical Trials Unit
    Jan 19, 2022

    Healthy Volunteer Study Trial in Québec (Drug: AT-527 + rosuvastatin, AT-527 + rosuvastatin)

    Completed
    • Healthy Volunteer Study
    • Drug: AT-527 + rosuvastatin
    • AT-527 + rosuvastatin
    • Québec, Montreal, Quebec, Canada
      Atea Study Site
    Feb 23, 2022

    Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect Trial in Minneapolis (Rosuvastatin 20mg, Placebo)

    Active, not recruiting
    • Cardiovascular Risk Factor
    • +2 more
    • Rosuvastatin 20mg
    • Placebo
    • Minneapolis, Minnesota
      Minneapolis Heart Institute Foundation
    Mar 18, 2022

    Chronic Hepatitis B Trial (HRS5091 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)

    Completed
    • Chronic Hepatitis B
    • HRS5091 Tablets
    • +6 more
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Dec 22, 2022

    Healthy Participants Trial in Salt Lake City (Rosuvastatin, Branebrutinib)

    Completed
    • Healthy Participants
    • Salt Lake City, Utah
      ICON (LPRA) - Salt Lake
    Feb 25, 2022

    Healthy Trial in Springfield, Dallas (Rosuvastatin, Pirtobrutinib)

    Completed
    • Healthy
    • Springfield, Missouri
    • +1 more
    Apr 14, 2022

    ST-segment Elevation Myocardial Infarction Trial in Damanhur (Rosuvastatin 20 mg ,40 mg, Atorvastatin 40mg,80mg)

    Completed
    • ST-segment Elevation Myocardial Infarction
    • Rosuvastatin 20 mg ,40 mg
    • Atorvastatin 40mg,80mg
    • Damanhūr, Egypt
      Damanhour University
    Jun 6, 2023

    Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)

    Completed
    • Intracerebral Hemorrhage
    • Szczecin, West Pomeranian, Poland
      Pomeranian Medical University
    Oct 16, 2023

    Healthy Trial in Salt Lake City (Lazertinib, Midazolam, Rosuvastatin)

    Completed
    • Healthy
    • Salt Lake City, Utah
      PRA Health Sciences
    Jun 22, 2022

    Healthy Participants Trial in Brooklyn (AZD5462, Midazolam, Rosuvastatin)

    Completed
    • Healthy Participants
    • Brooklyn, Maryland
      Research Site
    Oct 10, 2022